BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 34739452)

  • 1. Immediate adverse events following COVID-19 immunization. A cross-sectional study of 314,664 Italian subjects.
    Gianfredi V; Minerva M; Casu G; Capraro M; Chiecca G; Gaetti G; Mantecca Mazzocchi R; Musarò P; Berardinelli P; Basteri P; Bertini B; Ferri C; Odone A; Signorelli C; Alberti VF; Gastaldi G
    Acta Biomed; 2021 Oct; 92(S6):e2021487. PubMed ID: 34739452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To Study Adverse Effect following Immunization (AEFI) and COVID-19 Infection amongst COVID-19 Vaccine Benefeciaries.
    N PP; S CS; F JV; B AB; A KM; T DP; N GC; R IA
    J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccines Programs: adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia.
    Supangat ; Sakinah EN; Nugraha MY; Qodar TS; Mulyono BW; Tohari AI
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):58. PubMed ID: 34641944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
    Puspitarani F; Sitaresmi MN; Ahmad RA
    Front Public Health; 2022; 10():999354. PubMed ID: 36388348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and adverse events following COVID-19 vaccination among people with epilepsy: A cross-sectional study.
    Ong MJY; Khoo CS; Lee YX; Poongkuntran V; Tang CK; Choong YJ; Hod R; Tan HJ
    Epilepsia Open; 2023 Mar; 8(1):60-76. PubMed ID: 36214033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
    Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
    Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
    Christou-Ergos M; Wiley KE; Leask J
    Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination site.
    Signorelli C; Odone A; Gianfredi V; Capraro M; Kacerik E; Chiecca G; Scardoni A; Minerva M; Mantecca R; Musarò P; Brazzoli P; Basteri P; Bertini B; Esposti F; Ferri C; Alberti VA; Gastaldi G
    Ann Ig; 2021; 33(5):499-512. PubMed ID: 34113956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
    Rahmat H; Leelavathi M; Wan Ismail WF
    Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with intention for revaccination among patients with adverse events following immunization.
    Muñoz CE; Pham-Huy A; Pernica JM; Boucher FD; De Serres G; Vaudry W; Constantinescu C; Sadarangani M; Bettinger JA; Tapiéro B; Morris SK; McConnell A; Noya F; Halperin SA; Top KA;
    Vaccine; 2023 Oct; 41(42):6239-6247. PubMed ID: 37666696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India.
    Parida SP; Sahu DP; Singh AK; Alekhya G; Subba SH; Mishra A; Padhy BM; Patro BK
    J Med Virol; 2022 Jun; 94(6):2453-2459. PubMed ID: 35149993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adverse effects following immunisation degree after the administration COVID-19 vaccine of different platforms.
    Bermawi B; Donastin A; Sari NDK; Kurniasari DW; Adriansyah AA; Ferdiansyah MA; Rofananda IF; Surya PA
    Med J Malaysia; 2024 Mar; 79(2):124-127. PubMed ID: 38553914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
    Serhan M; Psihogios A; Kabir N; Bota AB; Mithani SS; Smith DP; Zhu DT; Greyson D; Wilson S; Fell D; Top KA; Bettinger JA; Wilson K
    Hum Vaccin Immunother; 2024 Dec; 20(1):2293550. PubMed ID: 38374618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    Subedi P; Yadav GK; Paudel B; Regmi A; Pyakurel P
    PLoS One; 2021; 16(12):e0260638. PubMed ID: 34932553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review.
    Bhandari B; Rayamajhi G; Lamichhane P; Shenoy AK
    Biomed Res Int; 2022; 2022():2911333. PubMed ID: 36017393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.
    Duijster JW; Lieber T; Pacelli S; Van Balveren L; Ruijs LS; Raethke M; Kant A; Van Hunsel F
    Front Immunol; 2023; 14():1078736. PubMed ID: 36793715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
    Jeon M; Kim J; Oh CE; Lee JY
    J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria.
    Shragai T; Adegoke OJ; Ikwe H; Sorungbe T; Haruna A; Williams I; Okonkwo R; Onu K; Asekun A; Gberikon M; Iwara E; Abimiku A; Rufai A; Okposen B; Gidudu J; Lam E; Bolu O
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccination: Is it a matter of concern?
    Kushwaha P; Pundhir A; Gahlot A
    J Family Med Prim Care; 2022 Jun; 11(6):2431-2436. PubMed ID: 36119229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.